Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

Total article views   Abstract views HTML views PDF downloads Totals
2,637 Dovepress* 2,165 271+ 277 2,436
PubMed Central* 0 201 74 201
Totals 2,165 472 351 2,637
*Since 1 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar